Cover Image
市場調查報告書

全球GCM (持續的血糖監測系統) 市場:用戶、醫療費償付政策、GCM零組件市場、糖尿病人口 (I型、II型) 、預測

Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type 1 & 2) Population & Forecast

出版商 Renub Research 商品編碼 581842
出版日期 內容資訊 英文 187 Pages; 163 Figures; 4 Tables
商品交期: 最快1-2個工作天內
價格
Back to Top
全球GCM (持續的血糖監測系統) 市場:用戶、醫療費償付政策、GCM零組件市場、糖尿病人口 (I型、II型) 、預測 Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type 1 & 2) Population & Forecast
出版日期: 2017年11月10日 內容資訊: 英文 187 Pages; 163 Figures; 4 Tables
簡介

全球CGM市場規模,預計至2024年達到40億美元的規模。

本報告提供全球11個國家的GCM (持續的血糖監測系統) 市場相關調查,全球GCM用戶數,市場、預測,各國市場佔有率,各國的糖尿病人口,GCM市場、預測,CGM用戶數,CGM的醫療費償付政策等相關彙整。

第1章 摘要整理

第2章 全球GCM用戶數

第3章 全球GCM市場、預測

第4章 各零件的GCM市場

  • 葡萄糖感測器市場 & 預測
  • GCM傳送器市場 & 預測

第5章 市場佔有率:各國

第6章 全球GCM (持續的血糖監測系統) 醫療費償付模式

第7章 全球FreeStyle Libre vs. GCM (持續的血糖監測系統)

第8章 美國:糖尿病人口

  • 美國的整體糖尿病人口
    • 美國的I型糖尿病人口
    • 美國的II型糖尿病人口

第9章 美國:GCM市場、預測

  • 美國的GCM市場:各零件
    • 葡萄糖感測器市場 & 預測
    • CGM傳送器市場 & 預測

第10章 美國:CGM用戶數

第11章 美國:CGM的醫療費償付

第12章 英國:糖尿病人口

第13章 英國:GCM市場 & 預測

第14章 英國:CGM用戶數

第15章 英國:CGM的醫療費償付

第16章 以色列:糖尿病人口

第17章 以色列:GCM市場 & 預測

第18章 以色列:CGM用戶數

第19章 以色列:CGM的醫療費償付

第20章 德國:糖尿病人口

第21章 德國:GCM市場 & 預測

第22章 德國:CGM用戶數

第23章 德國:CGM的醫療費償付

第24章 荷蘭:糖尿病人口

第25章 荷蘭:GCM市場 & 預測

第26章 荷蘭:CGM用戶數

第27章 荷蘭:CGM的醫療費償付

第28章 瑞典:糖尿病人口

第29章 瑞典:GCM市場 & 預測

第30章 瑞典:CGM用戶數

第31章 瑞典:CGM的醫療費償付

第32章 法國:糖尿病人口

第33章 法國:GCM市場 & 預測

第34章 法國:CGM用戶數

第35章 法國:CGM的醫療費償付

第36章 瑞士:糖尿病人口

第37章 瑞士:GCM市場 & 預測

第38章 瑞士:CGM用戶數

第39章 瑞士:CGM的醫療費償付

第40章 澳洲:糖尿病人口

第41章 澳洲:GCM市場 & 預測

第42章 澳洲:CGM用戶數

第43章 澳洲:CGM的醫療費償付

第44章 日本:糖尿病人口

第45章 日本:GCM市場 & 預測

第46章 日本:CGM用戶數

第47章 日本:CGM的醫療費償付

第48章 加拿大:糖尿病人口

第49章 加拿大:GCM市場 & 預測

第50章 加拿大:CGM用戶數

第51章 加拿大:CGM的醫療費償付

第52章 市場動態

目錄

Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2 components: glucose sensors and CGM transmitters. Transmitters & receivers along with sensors are known as standalone CGM systems, which are preinstalled by manufacturer. Sensors are disposable items, which is replaced after every 5-7 days. By geography, this market is studied with respect to major Industrialized Countries (United States, United Kingdom, Israel, Germany, France, Netherlands, Sweden, Switzerland, Australia, Japan and Canada).

United States has the Highest CGM Market Globally

CGM (Continuous Glucose Monitor) is extremely relevant to almost all age groups to manage diabetes efficiently and effectively. United States controls the global CGM Market. In Europe Germany and France CGM market has grown to a noticeable strength. According to many experts CGM is the best device for proper diabetes management for those having severe diabetes complications occurred periodically.

Countries Specific CGM Reimbursement details are covered in this Report

CGM reimbursement is still in its infancy stages in many countries but policy has been expanding over a period of time and addition of technological device under diabetes management is implemented by many countries. At present CGM is reimbursed for pediatric, gestational diabetes and Type 1 diabetes patients in some countries and it is expected that it will be accessible to all diabetes patients in due course of time. As countries are continuously expanding their diabetes management policy and several positive assessments are being done in favor of CGM it is expected to drive the market in future.

Renub Research latest study “Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the Global CGM Market. This 187 page report with 163 Figures and 4 Tables studies the Continuous Glucose Monitoring (CGM) market from 3 view points:

  • CGM Market
  • CGM Users
  • CGM Reimbursements Policy

Scope of the Report

  • CGM Market & Forecast: We have defined CGM market of 11 countries. Market data from 2010 to 2016 and Forecast from 2017 to 2024
  • CGM Users & Forecast: We have defined CGM number of Users of 11 countries. Market data from 2010 to 2016 and Forecast from 2017 to 2024
  • Reimbursement Policy: Report provides Reimbursement Policy on CGM for 11 countries individually along with global CGM (Continuous Glucose Monitoring) reimbursement model
  • Diabetes Population: Report covers 11 Countries Type 1 and Type 2 Diabetes Population Numbers and Forecast
  • Growth Factors for CGM: This topic studies the factors which is helping the CGM industry to grow
  • Challenges for CGM: This industry shows the problems being faced by the CGM technology

Countries Covered

  • 1. United States
  • 2. Canada
  • 3. Germany
  • 4. Australia
  • 5. France
  • 6. Netherlands
  • 7. Switzerland
  • 8. Sweden
  • 9. Israel
  • 10. United Kingdom
  • 11. Japan

Key Questions Answered in the Report?

  • What is the Global CGM Market & its growth forecast?
  • What are the Global CGM Users & its growth forecast?
  • What is the CGM market & forecast in 11 countries globally?
  • What is the CGM users & forecast in 11 countries globally?
  • What is the CGM reimbursement policy in each of these 11 countries?

Table of Contents

1. Executive Summary

2. Global-CGM User (2010-2024)

3. Global-CGM Market & Forecast (2010-2024)

4. By Components-CGM Market (2010-2024)

  • 4.1. Glucose Sensor Market & Forecast
  • 4.2. CGM Transmitter Market & Forecast

5. Market Share-By Countries

6. Global CGM (Continuous Glucose Monitoring) Reimbursement Model

7. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

8. United States-Diabetes Population (2010-2024)

  • 8.1. United States Total Diabetes Population
  • 8.1.1. United States Type 1 Diabetes Population
  • 8.1.2. United States Type 2 Diabetes Population

9. United States-CGM Market & Forecast

  • 9.1. United States-CGM Market by Components
    • 9.1.1. Glucose Sensor Market & Forecast
    • 9.1.2. CGM Transmitter Market & Forecast

10. United States-CGM User (2010-2024)

11. CGM Reimbursement in United States

12. United Kingdom-Diabetes Population (2010-2024)

  • 12.1. United Kingdom-Total Diabetes Population
    • 12.1.1. United Kingdom Type 1 Diabetes Population
    • 12.1.2. United Kingdom Type 2 Diabetes Population

13. United Kingdom-CGM Market & Forecast

  • 13.1. United Kingdom-CGM Market by Components
    • 13.1.1. Glucose Sensor Market & Forecast
    • 13.1.2. CGM Transmitter Market & Forecast

14. United Kingdom-CGM User (2010-2024)

15. CGM Reimbursement in United Kingdom

16. Israel-Diabetes Population (2010-2024)

  • 16.1. Israel-Total Diabetes Population & Forecast
    • 16.1.1. Type 1 Diabetes Population
    • 16.1.2. Type 2 Diabetes Population

17. Israel-CGM Market & Forecast

  • 17.1. Israel-CGM Market by Components
    • 17.1.1. Glucose Sensor Market & Forecast
    • 17.1.2. CGM Transmitter Market & Forecast

18. Israel-CGM User (2010-2024)

19. CGM Reimbursement in Israel

20. Germany-Diabetes Population (2010-2024)

  • 20.1. Germany-Total Diabetes Population
    • 20.1.1. Type 1 Diabetes Population
    • 20.1.2. Type 2 Diabetes Population

21. Germany-CGM Market & Forecast

  • 21.1. Germany-CGM Market by Components
    • 21.1.1. Glucose Sensor Market & Forecast
    • 21.1.2. CGM Transmitter Market & Forecast

22. Germany-CGM User (2010-2024)

23. CGM Reimbursement in Germany

24. Netherlands-Diabetes Population (2010-2024)

  • 24.1. Netherlands-Total Diabetes Population
    • 24.1.1. Type 1 Diabetes Population
    • 24.1.2. Type 2 Diabetes Population

25. Netherlands-CGM Market & Forecast

  • 25.1. Netherlands-CGM Market by Components
    • 25.1.1. Glucose Sensor Market & Forecast
    • 25.1.2. CGM Transmitter Market & Forecast

26. Netherlands-CGM User (2010-2024)

27. CGM Reimbursement in Netherlands

28. Sweden-Diabetes Population (2010-2024)

  • 28.1. Sweden-Total Diabetes Population & Forecast
    • 28.1.1. Type 1 Diabetes Population
    • 28.1.2. Type 2 Diabetes Population

29. Sweden-CGM Market & Forecast

  • 29.1. Sweden-CGM Market by Components
    • 29.1.1. Glucose Sensor Market & Forecast
    • 29.1.2. CGM Transmitter Market & Forecast

30. Sweden-CGM User (2010-2024)

31. CGM Reimbursement in Sweden

32. France-Diabetes Population (2010-2024)

  • 32.1. France-Diabetes Population
    • 32.1.1. Type 1 Diabetes Population
    • 32.1.2. Type 2 Diabetes Population

33. France-CGM Market & Forecast

  • 33.1. France-CGM Market by Components
    • 33.1.1. Glucose Sensor Market & Forecast
    • 33.1.2. CGM Transmitter Market & Forecast

34. France-CGM User (2010-2024)

35. CGM Reimbursement in France

36. Switzerland-Diabetes Population (2010-2024)

  • 36.1. Switzerland-Total Diabetes Population
    • 36.1.1. Type 1 Diabetes Population
    • 36.1.2. Type 2 Diabetes Population

37. Switzerland-CGM Market & Forecast

  • 37.1. Switzerland-CGM Market by Components
    • 37.1.1. Glucose Sensor Market & Forecast
    • 37.1.2. CGM Transmitter Market & Forecast

38. Switzerland-CGM User (2010-2024)

39. CGM Reimbursement in Switzerland

40. Australia-Diabetes Population (2010-2024)

  • 40.1. Australia-Total Diabetes Population
    • 40.1.1. Type 1 Diabetes Population
    • 40.1.2. Type 2 Diabetes Population

41. Australia-CGM Market & Forecast

  • 41.1. Australia-CGM Market by Components
    • 41.1.1. Glucose Sensor Market & Forecast
    • 41.1.2. CGM Transmitter Market & Forecast

42. Australia-CGM User (2010-2024)

43. CGM Reimbursement in Australia

44. Japan-Diabetes Population (2010-2024)

  • 44.1. Japan-Total Diabetes Population
    • 44.1.1. Type 1 Diabetes Population
    • 44.1.2. Type 2 Diabetes Population

45. Japan-CGM Market & Forecast

  • 45.1. Japan-CGM Market by Components
    • 45.1.1. Japan-Glucose Sensor Market & Forecast
    • 45.1.2. Japan-CGM Transmitter Market & Forecast

46. Japan-CGM User (2010-2024)

47. CGM Reimbursement in Japan

48. Canada-Diabetes Population (2010-2024)

  • 48.1. Canada Diabetes Population
    • 48.1.1. Type 1 Diabetes Population
    • 48.1.2. Type 2 Diabetes Population

49. Canada-CGM Market & Forecast

  • 49.1. Canada-CGM Market by Components
    • 49.1.1. Glucose Sensor Market & Forecast
    • 49.1.2. CGM Transmitter Market & Forecast

50. Canada-CGM User (2010-2024)

51. CGM Reimbursement in Canada

52. Market Dynamics

  • 52.1. Growth Drivers
    • 52.1.1. Continuous Positive Cost Effective Analysis by Several Countries
    • 52.1.2. CGM Technology Convenient for both Patients & Physicians
  • 52.2. Challenges
    • 52.2.1. Controversy regarding Clinical Benefits

List of Figures

  • Figure 2-1: Global-CGM User (Number), 2010-2016
  • Figure 2-2: Global-Forecast for CGM User (Number), 2017-2024
  • Figure 3-1: Global-CGM Market (Million US$), 2010-2016
  • Figure 3-2: Global-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 4-1: Global-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 4-2: Global-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 4-3: Global-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 4-4: Global-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 7-1: Abbott Freestyle Libre-User in Europe & Global (Number), May 2017
  • Figure 8-1: United States-Diabetes Population (Thousand), 2010-2016
  • Figure 8-2: United States-Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 8-3: United States-Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 8-4: United States-Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 8-5: United States: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 8-6: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 9-1: United States-CGM Market (Million US$), 2010-2016
  • Figure 9-2: United States-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 9-3: United States-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 9-4: United States-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 9-5: United States-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 9-6: United States-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 10-1: United States-CGM User (Number), 2010-2016
  • Figure 10-2: United States-Forecast for CGM User (Number), 2017-2024
  • Figure 12-1: United Kingdom: Diabetes Population (Thousand), 2010-2016
  • Figure 12-2: United Kingdom: Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 12-3: United Kingdom: Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 12-4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 12-5: United Kingdom: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 12-6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 13-1: United Kingdom-CGM Market (Million US$), 2010-2016
  • Figure 13-2: United Kingdom-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 13-3: United Kingdom-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 13-4: United Kingdom-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 13-5: United Kingdom-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 13-6: United Kingdom-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 14-1: United Kingdom-CGM User (Number), 2010-2014
  • Figure 14-2: United Kingdom-Forecast for CGM User (Number), 2017-2024
  • Figure 16-1: Israel: Diabetes Population (Thousand), 2010-2016
  • Figure 16-2: Israel: Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 16-3: Israel: Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 16-4: Israel: Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 16-5: Israel: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 16-6: Israel: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 17-1: Israel-CGM Market (Million US$), 2010-2016
  • Figure 17-2: Israel-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 17-3: Israel-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 17-4: Israel-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 17-5: Israel-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 17-6: Israel-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 18-1: Israel-CGM User (Number), 2010-2016
  • Figure 18-2: Israel-Forecast for CGM User (Number), 2017-2024
  • Figure 20-1: Germany: Diabetes Population (Thousand), 2010-2016
  • Figure 20-2: Germany: Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 20-3: Germany: Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 20-4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 20-5: Germany: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 20-6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 21-1: Germany-CGM Market (Million US$), 2010-2016
  • Figure 21-2: Germany-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 21-3: Germany-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 21-4: Germany-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 21-5: Germany-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 21-6: Germany-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 22-1: Germany-CGM User (Number), 2010-2016
  • Figure 22-2: Germany-Forecast for CGM User (Number), 2017-2024
  • Figure 24-1: Netherlands: Diabetes Population (Thousand), 2010-2016
  • Figure 24-2: Netherlands: Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 24-3: Netherlands: Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 24-4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 24-5: Netherlands: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 24-6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 25-1: Netherlands-CGM Market (Million US$), 2010-2016
  • Figure 25-2: Netherlands-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 25-3: Netherlands-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 25-4: Netherlands-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 25-5: Netherlands-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 25-6: Netherlands-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 26-1: Netherlands-CGM User (Number), 2010-2016
  • Figure 26-2: Netherlands-Forecast for CGM User (Number), 2017-2024
  • Figure 28-1: Sweden: Diabetes Population (Thousand), 2010-2016
  • Figure 28-2: Sweden: Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 28-3: Sweden: Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 28-4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 28-5: Sweden: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 28-6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 29-1: Sweden-CGM Market (Million US$), 2010-2016
  • Figure 29-2: Sweden-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 29-3: Sweden-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 29-4: Sweden-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 29-5: Sweden-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 29-6: Sweden-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 30-1: Sweden-CGM User (Number), 2010-2016
  • Figure 30-2: Sweden-Forecast for CGM User (Number), 2017-2024
  • Figure 32-1: France-Diabetes Population (Thousand), 2010-2016
  • Figure 32-2: France-Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 32-3: France-Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 32-4: France-Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 32-5: France-Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 32-6: France-Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 33-1: France-CGM Market (Million US$), 2010-2016
  • Figure 33-2: France-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 33-3: France-Glucose Sensor Market (Million), 2010-2016
  • Figure 33-4: France-Forecast for Glucose Sensor Market (Million), 2017-2024
  • Figure 33-5: France-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 33-6: France-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 34-1: France-CGM User (Number), 2010-2016
  • Figure 34-2: France-Forecast for CGM User (Number), 2017-2024
  • Figure 36-1: Switzerland: Diabetes Population (Thousand), 2010-2016
  • Figure 36-2: Switzerland: Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 36-3: Switzerland: Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 36-4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 36-5: Switzerland: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 36-6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 37-1: Switzerland-CGM Market (Million US$), 2010-2016
  • Figure 37-2: Switzerland-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 37-3: Switzerland-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 37-4: Switzerland-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 37-5: Switzerland-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 37-6: Switzerland-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 38-1: Switzerland-CGM User (Number), 2010-2016
  • Figure 38-2: Switzerland-Forecast for CGM User (Number), 2017-2024
  • Figure 40-1: Australia: Diabetes Population (Thousand), 2010-2016
  • Figure 40-2: Australia: Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 40-3: Australia: Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 40-4: Australia: Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 40-5: Australia: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 40-6: Australia: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 41-1: Australia-CGM Market (Million US$), 2010-2016
  • Figure 41-2: Australia-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 41-3: Australia-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 41-4: Australia-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 41-5: Australia-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 41-6: Australia-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 42-1: Australia-CGM User (Number), 2010-2016
  • Figure 42-2: Australia-Forecast for CGM User (Number), 2017-2024
  • Figure 44-1: Japan: Diabetes Population (Thousand), 2010-2016
  • Figure 44-2: Japan: Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 44-3: Japan: Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 44-4: Japan: Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 44-5: Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 44-6: Japan: Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 45-1: Japan-CGM Market (Million US$), 2010-2016
  • Figure 45-2: Japan-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 45-3: Japan-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 45-4: Japan-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 45-5: Japan-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 45-6: Japan-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 46-1: Japan-CGM User (Number), 2010-2016
  • Figure 46-2: Japan-Forecast for CGM User (Number), 2017-2024
  • Figure 48-1: Canada-Diabetes Population (Thousand), 2010-2016
  • Figure 48-2: Canada-Forecast for Diabetes Population (Thousand), 2017-2024
  • Figure 48-3: Canada-Type 1 Diabetes Population (Thousand), 2010-2016
  • Figure 48-4: Canada-Forecast for Type 1 Diabetes Population (Thousand), 2017-2024
  • Figure 48-5: Canada-Type 2 Diabetes Population (Thousand), 2010-2016
  • Figure 48-6: Canada-Forecast for Type 2 Diabetes Population (Thousand), 2017-2024
  • Figure 49-1: Canada-CGM Market (Million US$), 2010-2016
  • Figure 49-2: Canada-Forecast for CGM Market (Million US$), 2017-2024
  • Figure 49-3: Canada-Glucose Sensor Market (Million US$), 2010-2016
  • Figure 49-4: Canada-Forecast for Glucose Sensor Market (Million US$), 2017-2024
  • Figure 49-5: Canada-CGM Transmitter Market (Million US$), 2010-2016
  • Figure 49-6: Canada-Forecast for CGM Transmitter Market (Million US$), 2017-2024
  • Figure 50-1: Canada-CGM User (Number), 2010-2016
  • Figure 50-2: Canada-Forecast for CGM User (Number), 2017-2024

List of Tables

  • Table 3-1: Global-CGM Market Share (Percent), 2010-2016
  • Table 3-2: Global-Forecast for CGM Market Share (Percent), 2017-2024
  • Table 6-1: Current Status of Global Real-Time Continuous Glucose Monitoring Coverage and Reimbursement, 2017
  • Table 7-1: Abbott Freestyle Libre vs. CGM
Back to Top